Since then, many study groups have tested AQP4-IgG in patients with NMO or NMOSD, with the reported frequency varying according to the assay, e.g., immunofluorescence, immunoprecipitation, radioimmunoprecipitation or CBA [18–22]. Here, AQP4 is linked to neuromyelitis optica.